PrimeRFP SCOUT · Federal Contract Recompete Brief

36C26022F0036Eo14042 tyvasco — United Therapeutics Corp

United Therapeutics Corp holds $3.8M across 190 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 1 related award under parent 36F79720D0104. The prior award was single-bid — competitive dynamics may favor a challenge. PoP ended Oct 31, 2022 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

260-Network Contract Office 20 (36C260)

Awarding office

United Therapeutics Corp

Recipient

Oct 31, 2022

PoP end

$296K

Obligated

$296K

Potential

325412

NAICS

6505

PSC

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs United Therapeutics Corp — $90

Contract facts

Federal

Contract number36C26022F0036

Also listed as36C260-22-F-0036

Also listed as36F79720D0104-36C26022F0036

Agency260-Network Contract Office 20 (36C260)

Awarding office260-Network Contract Office 20 (36C260)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentUnited Therapeutics Corp

CAGE3P7X8

UEIKK5FBFA43JS7

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDV36F79720D0104

Place of performanceSILVER SPRING MD

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startNov 1, 2021

PoP end (current)Oct 31, 2022

Obligated$296K

Current value$296K

Potential value$296K

EO14042 TYVASCO is a federal award for 260-Network Contract Office 20 (36C260) held by United Therapeutics Corp. Estimated value $296K ($296K obligated). Current period of performance ends Oct 31, 2022. Last award drew 1 bidder. Place of performance: SILVER SPRING MD.

Recompete timing

Public

● Past PoP end (1390 days ago)

Current PoP ended Oct 31, 2022 (1390 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

United Therapeutics Corp — $3.8M obligated across 190 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($3.8M) · all agencies

Department of Veterans Affairs (VA)$3.7M · 97%Department of Justice (DOJ)$118K · 3%

Open full company profile →

Related awards

Same parent · incumbent

36C26026F0064

TYVASO KITS & CARTRIDGES

$379K

Sep 30, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C26022F0036?

36C26022F0036 (Eo14042 tyvasco) is a 260-Network Contract Office 20 (36C260) award with a potential value of $296K, currently held by United Therapeutics Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C260-22-F-0036?

36C260-22-F-0036 is the dashed form of PIID 36C26022F0036 (Eo14042 tyvasco), held by United Therapeutics Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C26022F0036?

260-Network Contract Office 20 (36C260) awarded 36C26022F0036 to United Therapeutics Corp (potential $296K).

Who is the incumbent on 36C26022F0036?

United Therapeutics Corp is the incumbent with $3.8M across 190 related awards in SCOUT’s public footprint. The current period of performance ends Oct 31, 2022.

When does United Therapeutics Corp’s 36C26022F0036 come up for recompete?

SCOUT tracks a period-of-performance end of Oct 31, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 25, 2026 · refreshed monthlyLatest procurement action Nov 23, 2022